User:Frida Nyberg
Jump to navigation
Jump to search
Affiliation
Uppsala university, Department of Medical sciences.
Doctoral student in Cancer pharmacology.
Research
Three-dimensional cancer cell models, drug repurposing and precision medicine in pre-clinical cancer pharmacology.
Publications
Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity[1] Jul 12, 2019, Journal of Pathology. PMID: 31298733
Targeting tumor cells based on Phosphodiesterase 3A expression[2]. Oct 26, 2017, Experimental Cell Research. PMID: 29107068
Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition[3]. Dec 13, 2016, Cell Reports. PMID: 27974212
References
- ^ Niklasson, Mia; Bergström, Tobias; Jarvius, Malin; Sundström, Anders; Nyberg, Frida; Haglund, Caroline; Larsson, Rolf; Westermark, Bengt; Segerman, Bo (2019-07-12). "Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity". The Journal of Pathology. doi:10.1002/path.5317. ISSN 1096-9896. PMID 31298733.
- ^ Nazir, Madiha; Senkowski, Wojciech; Nyberg, Frida; Blom, Kristin; Edqvist, Per-Henrik; Jarvius, Malin; Andersson, Claes; Gustafsson, Mats G.; Nygren, Peter (12 15, 2017). "Targeting tumor cells based on Phosphodiesterase 3A expression". Experimental Cell Research. 361 (2): 308–315. doi:10.1016/j.yexcr.2017.10.032. ISSN 1090-2422. PMID 29107068.
{{cite journal}}: Check date values in:|date=(help) - ^ Segerman, Anna; Niklasson, Mia; Haglund, Caroline; Bergström, Tobias; Jarvius, Malin; Xie, Yuan; Westermark, Ann; Sönmez, Demet; Hermansson, Annika (12 13, 2016). "Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition". Cell Reports. 17 (11): 2994–3009. doi:10.1016/j.celrep.2016.11.056. ISSN 2211-1247. PMID 27974212.
{{cite journal}}: Check date values in:|date=(help)